Kodiak Sciences (KOD) Total Liabilities (2016 - 2026)
Kodiak Sciences (KOD) reported Total Liabilities of $193.9 million for Q1 2026, up 2.56% on a YoY basis from $189.1 million in Q1 2025, and little changed quarter-over-quarter from $194.1 million in Q4 2025.
Kodiak Sciences (KOD) Total Liabilities (2016 - 2026) Analysis & Trends
Kodiak Sciences has reported Total Liabilities for 11 years, with the latest figure at $193.9 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 2.56% year-over-year to $193.9 million; the trailing twelve-month figure through Mar 2026 stood at $193.9 million (up 2.56% YoY), and the FY2025 full-year result was $194.1 million, up 4.78% from the prior year.
- Total Liabilities for Q1 2026 stood at $193.9 million, roughly flat from $194.1 million in the prior quarter.
- The five-year high for Total Liabilities was $252.9 million in Q1 2022, with the low at $185.3 million in Q4 2024.
- Historically, Total Liabilities has averaged $214.6 million across 5 years, with a median of $194.4 million in 2025.
- Annual changes were most pronounced in 2022 — Total Liabilities advanced 19.83% — and 2024, when it dropped 25.52%.
- Kodiak Sciences' Total Liabilities stood at $230.5 million in 2022, then decreased by 7.32% to $213.6 million in 2023, then slipped by 13.25% to $185.3 million in 2024, then advanced by 4.78% to $194.1 million in 2025, then fell by 0.13% to $193.9 million in 2026.
- The last three Total Liabilities figures came in at $193.9 million (Q1 2026), $194.1 million (Q4 2025), and $194.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 19.51 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 10.44 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 137.56 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 193.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 193.91 Mn |
| Dec 31, 2025 | 194.15 Mn |
| Sep 30, 2025 | 194.38 Mn |
| Jun 30, 2025 | 186.44 Mn |
| Mar 31, 2025 | 189.07 Mn |
| Dec 31, 2024 | 185.29 Mn |
| Sep 30, 2024 | 187.30 Mn |
| Jun 30, 2024 | 187.07 Mn |
| Mar 31, 2024 | 193.57 Mn |
| Dec 31, 2023 | 213.59 Mn |
| Sep 30, 2023 | 245.24 Mn |
| Jun 30, 2023 | 251.18 Mn |
| Mar 31, 2023 | 247.75 Mn |
| Dec 31, 2022 | 230.46 Mn |
| Sep 30, 2022 | 244.46 Mn |
| Jun 30, 2022 | 250.97 Mn |
| Mar 31, 2022 | 252.90 Mn |
| Dec 31, 2021 | 240.90 Mn |
| Sep 30, 2021 | 231.89 Mn |
| Jun 30, 2021 | 218.17 Mn |